Liarozole inhibits transforming growth factor-β3-mediated extracellular matrix formation in human three-dimensional leiomyoma cultures

Fertility and Sterility

Volumn 102, Issue 1, 2014, Pages

  Levy, Gary ^a,b   Malik, Minnie ^b   Britten, Joy ^b   Gilden, Melissa ^b   Segars, James ^a,b   Catherino, William H ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Extracellular matrix; leiomyoma; liarozole; three dimensional model; transforming growth factor beta

Indexed keywords

COLLAGEN; COLLAGEN 1A1; FIBRONECTIN; LIAROZOLE; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; VERSICAN;

ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LEIOMYOMA; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE CULTURE; WESTERN BLOTTING;

EXTRACELLULAR MATRIX; LEIOMYOMA; LIAROZOLE; THREE-DIMENSIONAL MODEL; TRANSFORMING GROWTH FACTOR-BETA;

ANTINEOPLASTIC AGENTS, HORMONAL; CELL CULTURE TECHNIQUES; COLLAGEN TYPE I; DOWN-REGULATION; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; HUMANS; IMIDAZOLES; LEIOMYOMA; MYOMETRIUM; TRANSFORMING GROWTH FACTOR BETA3; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS; VERSICANS;

EID: 84903385302     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.03.042     Document Type: Article

References (46)

1. G. Levy, M.J. Hill, S. Beall, S.M. Zarek, J.H. Segars, and W.H. Catherino Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances J Assist Reprod Genet 29 2012 703 712
2. D.D. Baird, D.B. Dunson, M.C. Hill, D. Cousins, and J.M. Schectman High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence Am J Obstet Gynecol 188 2003 100 107
3. C.L. Walker, and E.A. Stewart Uterine fibroids: The elephant in the room Science 308 2005 1589 1592
4. M. Payson, P. Leppert, and J. Segars Epidemiology of myomas Obstet Gynecol Clin North Am 33 2006 1 11
5. E.R. Myers, M.D. Barber, T. Gustilo-Ashby, G. Couchman, D.B. Matchar, and D.C. McCrory Management of uterine leiomyomata: what do we really know? Obstet Gynecol 100 2002 8 17
6. J. Lee, M.J. Cuddihy, and N.A. Kotov Three-dimensional cell culture matrices: state of the art Tissue Eng Part B Rev 14 2008 61 86
7. H.A. Adissu, E.K. Asem, and S.A. Lelievre Three-dimensional cell culture to model epithelia in the female reproductive system Reprod Sci 14 2007 11 19
8. M. Malik, and W.H. Catherino Development and validation of a three-dimensional in vitro model for uterine leiomyoma and patient-matched myometrium Fertil Steril 97 2012 1287 1293
9. M. Malik, J. Norian, D. McCarthy-Keith, J. Britten, and W.H. Catherino Why leiomyomas are called fibroids: The central role of extracellular matrix in symptomatic women Semin Reprod Med 28 2010 169 179
10. P.C. Leppert, W.H. Catherino, and J.H. Segars A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays Am J Obstet Gynecol 195 2006 415 420
11. Y. Liu Renal fibrosis: new insights into the pathogenesis and therapeutics Kidney Int 69 2006 213 217
12. B.C. Willis, and Z. Borok TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease Am J Physiol Lung Cell Mol Physiol 293 2007 L525 L534
13. Y. Yata, P. Gotwals, V. Koteliansky, and D.C. Rockey Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy Hepatology 35 2002 1022 1030
14. P. Bonniaud, P.J. Margetts, K. Ask, K. Flanders, J. Gauldie, and M. Kolb TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis J Immunol 175 2005 5390 5395
15. J.M. Norian, M. Malik, C.Y. Parker, D. Joseph, P.C. Leppert, and J.H. Segars et al. Transforming growth factor β3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas Reprod Sci 16 2009 1153 1164
16. D.S. Joseph, M. Malik, S. Nurudeen, and W.H. Catherino Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3 Fertil Steril 93 2010 1500 1508
17. A. Arici, and I. Sozen Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation Fertil Steril 73 2000 1006 1011
18. N. Chegini Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder Semin Reprod Med 28 2010 180 203
19. E. Levens, X. Luo, L. Ding, R.S. Williams, and N. Chegini Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling Mol Hum Reprod 11 2005 489 494
20. X. Luo, J. Xu, and N. Chegini Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells Reprod Biol Endocrinol 1 2003 125
21. P. Bonniaud, M. Kolb, T. Galt, J. Robertson, C. Robbins, and M. Stampfli et al. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis J Immunol 173 2004 2099 2108
22. M. Malik, J. Webb, and W.H. Catherino Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells Clin Endocrinol (Oxf) 69 2008 462 470
23. W.H. Catherino, and M. Malik Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure Fertil Steril 87 2007 1388 1398
24. D.I. Axel, A. Frigge, J. Dittmann, H. Runge, I. Spyridopoulos, and R. Riessen et al. All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells Cardiovasc Res 49 2001 851 862
25. B. Zirn, B. Samans, C. Spangenberg, N. Graf, M. Eilers, and M. Gessler All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo Oncogene 24 2005 5246 5251
26. S.B. Jakowlew, H. Zakowicz, and T.W. Moody Retinoic acid down-regulates VPAC(1) receptors and TGF-beta 3 but up-regulates TGF-beta 2 in lung cancer cells Peptides 21 2000 1831 1837
27. J. Van Wauwe, M.C. Coene, W. Cools, J. Goossens, W. Lauwers, and L. Le Jeune et al. Liarozole fumarate inhibits the metabolism of 4-keto-All-trans- retinoic acid Biochem Pharmacol 47 1994 737 741
28. R. De Coster, W. Wouters, R. Van Ginckel, D. End, M. Krekels, and M.C. Coene et al. Experimental studies with liarozole (R 75,251): An antitumoral agent which inhibits retinoic acid breakdown J Steroid Biochem Mol Biol 43 1992 197 201
29. G. Smets, R. Van Ginckel, G. Daneels, M. Moeremans, J. Van Wauwe, and M.C. Coene et al. Liarozole, an antitumor drug, modulates cytokeratin expression in the Dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid Prostate 27 1995 129 140
30. J. Van heusden, M. Borgers, F. Ramaekers, B. Xhonneux, W. Wouters, and R. De Coster et al. Liarozole potentiates the all-trans-retinoic acid-induced structural remodelling in human breast carcinoma MCF-7 cells in vitro Eur J Cell Biol 71 1996 89 98
31. Liarozole. Liarozole fumarate, Liazal, R 75251, R 85246 Drugs R D 2 1999 427 430
32. J. Van heusden, W. Wouters, F.C. Ramaekers, M.D. Krekels, L. Dillen, and M. Borgers et al. The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells Br J Cancer 77 1998 1229 1235
33. E. Pavez Lorie, A. Ganemo, M. Borgers, L. Wouters, S. Blockhuys, and L. van de Plassche et al. Expression of retinoid-regulated genes in lamellar ichthyosis vs. healthy control epidermis: changes after oral treatment with liarozole Acta Derm Venereol 89 2009 12 20
34. M. Gilden, M. Malik, J. Britten, T. Delgado, G. Levy, and W.H. Catherino Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent Fertil Steril 98 2012 1557 1562
35. M. Malik, and W.H. Catherino Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays Fertil Steril 87 2007 1166 1172
36. W. Catherino, A. Salama, C. Potlog-Nahari, P. Leppert, J. Tsibris, and J. Segars Gene expression studies in leiomyomata: new directions for research Semin Reprod Med 22 2004 83 90
37. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
38. B.S. Lee, and R.A. Nowak Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta J Clin Endocrinol Metab 86 2001 913 920
39. P.C. Leppert, T. Baginski, C. Prupas, W.H. Catherino, S. Pletcher, and J.H. Segars Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium Fertil Steril 82 Suppl 3 2004 1182 1187
40. A. Vahlquist, S. Blockhuys, P. Steijlen, K. van Rossem, B. Didona, and D. Blanco et al. Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial Br J Dermatol 170 2014 173 181
41. C.J. Verfaille, F.P. Vanhoutte, C. Blanchet-Bardon, M.A. van Steensel, and P.M. Steijlen Oral liarozole vs. acitretin in the treatment of ichthyosis: A phase II/III multicentre, double-blind, randomized, active-controlled study Br J Dermatol 156 2007 965 973
42. J. Berth-Jones, G. Todd, P.E. Hutchinson, K. Thestrup-Pedersen, and F.P. Vanhoutte Treatment of psoriasis with oral liarozole: A dose-ranging study Br J Dermatol 143 2000 1170 1176
43. V.A. Miller, J.R. Rigas, J.R. Muindi, W.P. Tong, E. Venkatraman, and M.G. Kris et al. Modulation of all-trans retinoic acid pharmacokinetics by liarozole Cancer Chemother Pharmacol 34 1994 522 526
44. Q. Xu, and J.B. Kopp Retinoid and TGF-beta families: crosstalk in development, neoplasia, immunity, and tissue repair Semin Nephrol 32 2012 287 294
45. X. Wen, Y. Li, K. Hu, C. Dai, and Y. Liu Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells Am J Pathol 167 2005 947 957
46. L.L. Hoover, E.G. Burton, M.L. O'Neill, B.A. Brooks, S. Sreedharan, and N.A. Dawson et al. Retinoids regulate TGFβ signaling at the level of Smad2 phosphorylation and nuclear accumulation Biochim Biophys Acta 1783 2008 2279 2286